Remimazolam versus propofol for deep sedation during Endoscopic Ultrasound (EUS) procedures. A randomized controlled trial.

Brief summary (registry, in English)

To compare a remimazolam-based sedation regimen managed by endoscopists to a propofol-based sedation regimen performed by anesthesiologists during EUS gastrointestinal procedures.

What you commit to

• Study type: Interventional · Phase 4
• Planned participants: 332
• 1 site in 1 country
• Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of EU CTIS (euclinicaltrials.eu). It describes the study design.

AI-kivonat: who the study is looking for

Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults who are booked for a planned endoscopic ultrasound of the digestive tract as outpatients. It compares two ways of giving deep sedation.

Age

Over 18 years

Sex

All sexes can join

Main reasons for not taking part

• Urgent endoscopic ultrasound procedures
• Known reasons why propofol or remimazolam cannot be used
• Procedures that need a breathing tube through the mouth
• Pregnant or breastfeeding women
• Inpatient procedures

Read by machine on 9 Nov 2026.

Who cannot take part

Copied verbatim from EU CTIS (euclinicaltrials.eu) and grouped by topic. Only the trial team decides who can take part.

Who the study is looking for

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on EU CTIS (euclinicaltrials.eu)

Sites (1)

Sites in registry order. Save your city in your profile to sort them by distance.

Are you the coordinator? Confirm the details